Azucena Reyes, diagnosed with stage 3B colon cancer at 32, highlights the importance of seeking medical evaluation for symptoms regardless of age as cases rise among younger populations.

Colorectal cancer is increasing among adults younger than 50, with the fastest growth observed in Hispanic and Latino populations in the United States. Azucena Reyes, who was diagnosed with stage 3B colon cancer at age 32, faced initial delays in diagnosis because doctors believed she was too young and did not fit the typical profile for the disease.

Challenges in Early Diagnosis

In 2015, Reyes experienced persistent nausea and stomach pain that led to the discovery of a tumor. Despite surgery, she was initially told the tumor could not be cancerous due to her age and ethnicity. Two months later, the tumor returned, resulting in a formal diagnosis. Reyes notes that at the time of her diagnosis, there was a lack of awareness and advocacy for younger patients.

Shifting Screening Guidelines

The American Cancer Society lowered the recommended screening age to 45 in 2018, with the U.S. Preventive Services Task Force following in 2021. Medical experts emphasize that individuals with warning symptoms should seek diagnostic testing regardless of age. For those under 45, doctors may suggest non-colonoscopy options like stool-based tests if insurance does not cover screening for asymptomatic patients.

Advocacy and Long-term Recovery

Reyes underwent 12 rounds of chemotherapy, which resulted in lasting health effects, including digestive issues and thyroid function changes. She now serves on the Colorectal Cancer Alliance’s Never Too Young Taskforce, focusing on providing information and support to the Spanish-speaking community to address disparities in access to cancer resources.